Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Index by author

March 01, 1996; Volume 276,Issue 3
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Abbruscato, T J

    1. You have access
      Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
      T J Abbruscato, S A Williams, A Misicka, A W Lipkowski, V J Hruby and T P Davis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1049-1057;
  2. Adkison, K D

    1. You have access
      Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter.
      K D Adkison and D D Shen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1189-1200;
  3. Alaoui-Jamali, M

    1. You have access
      Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response.
      T Wang, X Chen, R L Schecter, S Baruchel, M Alaoui-Jamali, D Melnychuk and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1169-1173;
  4. Ali, M

    1. You have access
      Effects of bombesin family peptides and antagonists on guinea pig nasal mucosal secretion.
      M Ali, A Z Gawin and J N Baraniuk
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1266-1271;
  5. Almazan, G

    1. You have access
      Ontogenic differences in the functions of myocardial alpha1 adrenoceptor subtypes in rats.
      X F Deng, S Chemtob, G Almazan and D R Varma
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1155-1161;
  6. Asin, K E

    1. You have access
      Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
      C W Lin, B R Bianchi, T R Miller, M A Stashko, S S Wang, P Curzon, L Bednarz, K E Asin and D R Britton
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1022-1029;
  7. Auer-Barth, S

    1. You have access
      Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines.
      M Leist, S Auer-Barth and A Wendel
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 968-976;

B

  1. Back, D J

    1. You have access
      Theophylline metabolism in human liver microsomes: inhibition studies.
      J F Tjia, J Colbert and D J Back
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 912-917;
  2. Baeyens, J M

    1. You have access
      Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
      M Ocaña, M Barrios and J M Baeyens
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1136-1142;
  3. Banick, P D

    1. You have access
      Functional inhibition of rat polymorphonuclear leukocyte B2 integrins by hyperbaric oxygen is associated with impaired cGMP synthesis.
      Q Chen, P D Banick and S R Thom
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 929-933;
  4. Baraniuk, J N

    1. You have access
      Effects of bombesin family peptides and antagonists on guinea pig nasal mucosal secretion.
      M Ali, A Z Gawin and J N Baraniuk
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1266-1271;
  5. Barrios, M

    1. You have access
      Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
      M Ocaña, M Barrios and J M Baeyens
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1136-1142;
  6. Baruchel, S

    1. You have access
      Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response.
      T Wang, X Chen, R L Schecter, S Baruchel, M Alaoui-Jamali, D Melnychuk and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1169-1173;
  7. Batist, G

    1. You have access
      Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response.
      T Wang, X Chen, R L Schecter, S Baruchel, M Alaoui-Jamali, D Melnychuk and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1169-1173;
  8. Baumann, H

    1. You have access
      Altered disposition and antidepressant activity of imipramine in transgenic mice with elevated alpha-1-acid glycoprotein.
      S D Yoo, J W Holladay, T K Fincher, H Baumann and M J Dewey
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 918-922;
  9. Bednarz, L

    1. You have access
      Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
      C W Lin, B R Bianchi, T R Miller, M A Stashko, S S Wang, P Curzon, L Bednarz, K E Asin and D R Britton
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1022-1029;
  10. Benjamin, C W

    1. You have access
      The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion.
      B M Taylor, W E Fleming, C W Benjamin, Y Wu, W R Mathews and F F Sun
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1224-1231;
  11. Berger, S P

    1. You have access
      Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization.
      M S Reid, K Hsu, B K Tolliver, C A Crawford and S P Berger
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1244-1256;
  12. Bergman, J

    1. You have access
      Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
      J Bergman, R D Spealman, B K Madras and S Rosenzweig-Lipson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 942-950;
  13. Bernat, A

    1. You have access
      DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
      J M Herbert, A Bernat, F Dol, J P Hérault, B Crépon and J C Lormeau
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1030-1038;
  14. Bianchi, B R

    1. You have access
      Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
      C W Lin, B R Bianchi, T R Miller, M A Stashko, S S Wang, P Curzon, L Bednarz, K E Asin and D R Britton
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1022-1029;
  15. Billingsley, M L

    1. You have access
      Induction of apoptosis by organotin compounds in vitro: neuronal protection with antisense oligonucleotides directed against stannin.
      T A Thompson, J M Lewis, N S Dejneka, W B Severs, R Polavarapu and M L Billingsley
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1201-1216;
  16. Bixler, M A

    1. You have access
      Comparison of the effects of typical and atypical anxiolytics on learning in monkeys and rats.
      P J Winsauer, M A Bixler and P C Mele
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1111-1127;
  17. Böhm, M

    1. You have access
      Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
      R H Schwinger, J Müller-Ehmsen, M Böhm and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1180-1188;
  18. Bossuyt, X

    1. You have access
      Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
      X Bossuyt, M Müller, B Hagenbuch and P J Meier
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 891-896;
  19. Bottlaender, M

    1. You have access
      Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.
      L Schmid, M Bottlaender, E Brouillet, C Fuseau and M Mazière
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 977-983;
  20. Britton, D R

    1. You have access
      Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
      C W Lin, B R Bianchi, T R Miller, M A Stashko, S S Wang, P Curzon, L Bednarz, K E Asin and D R Britton
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1022-1029;
  21. Brouillet, E

    1. You have access
      Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.
      L Schmid, M Bottlaender, E Brouillet, C Fuseau and M Mazière
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 977-983;
  22. Bustamante, D

    1. You have access
      Effects of intravenous nonsteroidal antiinflammatory drugs on a C-fiber reflex elicited by a wide range of stimulus intensities in the rat.
      D Bustamante, C Paeile, J C Willer and D Le Bars
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1232-1243;

C

  1. Chassaing, G

    1. You have access
      Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
      S Sagan, G Chassaing, L Pradier and S Lavielle
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1039-1048;
  2. Chastain, M

    1. You have access
      Evaluation of activated protein C on canine infarct size in a nonthrombotic model of myocardial reperfusion injury.
      R A Hahn, B R MacDonald, M Chastain, B W Grinnell and P J Simpson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1104-1110;
  3. Chemtob, S

    1. You have access
      Ontogenic differences in the functions of myocardial alpha1 adrenoceptor subtypes in rats.
      X F Deng, S Chemtob, G Almazan and D R Varma
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1155-1161;
  4. Chen, C F

    1. You have access
      The vasorelaxing action of rutaecarpine: direct paradoxical effects on intracellular calcium concentration of vascular smooth muscle and endothelial cells.
      G J Wang, J Shan, P K Pang, M C Yang, C J Chou and C F Chen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1016-1021;
  5. Chen, Q

    1. You have access
      Functional inhibition of rat polymorphonuclear leukocyte B2 integrins by hyperbaric oxygen is associated with impaired cGMP synthesis.
      Q Chen, P D Banick and S R Thom
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 929-933;
  6. Chen, X

    1. You have access
      Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response.
      T Wang, X Chen, R L Schecter, S Baruchel, M Alaoui-Jamali, D Melnychuk and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1169-1173;
  7. Chiu, N

    1. You have access
      Stimulation of renin secretion by the phosphodiesterase IV inhibitor rolipram.
      N Chiu, I Park and I A Reid
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1073-1077;
  8. Choo, K H

    1. You have access
      Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
      J Liu, Y Liu, A E Michalska, K H Choo and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1216-1223;
  9. Chou, C J

    1. You have access
      The vasorelaxing action of rutaecarpine: direct paradoxical effects on intracellular calcium concentration of vascular smooth muscle and endothelial cells.
      G J Wang, J Shan, P K Pang, M C Yang, C J Chou and C F Chen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1016-1021;
  10. Cohen, J

    1. You have access
      Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium.
      O Porat, D Neumann, O Zamir, S Nachshon, E Feigin, J Cohen and N Zamir
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1162-1168;
  11. Cohen, M L

    1. You have access
      Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein.
      D A Cox and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1095-1103;
  12. Colbert, J

    1. You have access
      Theophylline metabolism in human liver microsomes: inhibition studies.
      J F Tjia, J Colbert and D J Back
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 912-917;
  13. Cox, D A

    1. You have access
      Selective enhancement of 5-hydroxytryptamine-induced contraction of porcine coronary artery by oxidized low-density lipoprotein.
      D A Cox and M L Cohen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1095-1103;
  14. Crawford, C A

    1. You have access
      Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization.
      M S Reid, K Hsu, B K Tolliver, C A Crawford and S P Berger
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1244-1256;
  15. Crépon, B

    1. You have access
      DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
      J M Herbert, A Bernat, F Dol, J P Hérault, B Crépon and J C Lormeau
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1030-1038;
  16. Cryan, J

    1. You have access
      Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.
      F J Dumont, H Ok, S Lin, C A Kastner, J Cryan, M M Martin, G Wiederrecht and M J Staruch
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1078-1088;
  17. Curzon, P

    1. You have access
      Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
      C W Lin, B R Bianchi, T R Miller, M A Stashko, S S Wang, P Curzon, L Bednarz, K E Asin and D R Britton
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1022-1029;

D

  1. Davies, M P

    1. You have access
      Dual actions of the novel class III antiarrhythmic drug NE-10064 on delayed potassium channel currents in guinea pig ventricular and sinoatrial node cells.
      M P Davies, L C Freeman and R S Kass
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1149-1154;
  2. Davis, M J

    1. You have access
      Calcium dependence of indolactam-mediated contractions in resistance vessels.
      M A Hill, M J Davis, J Song and H Zou
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 867-874;
  3. Davis, T P

    1. You have access
      Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
      T J Abbruscato, S A Williams, A Misicka, A W Lipkowski, V J Hruby and T P Davis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1049-1057;
  4. Dejneka, N S

    1. You have access
      Induction of apoptosis by organotin compounds in vitro: neuronal protection with antisense oligonucleotides directed against stannin.
      T A Thompson, J M Lewis, N S Dejneka, W B Severs, R Polavarapu and M L Billingsley
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1201-1216;
  5. Deng, X F

    1. You have access
      Ontogenic differences in the functions of myocardial alpha1 adrenoceptor subtypes in rats.
      X F Deng, S Chemtob, G Almazan and D R Varma
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1155-1161;
  6. Dewey, M J

    1. You have access
      Altered disposition and antidepressant activity of imipramine in transgenic mice with elevated alpha-1-acid glycoprotein.
      S D Yoo, J W Holladay, T K Fincher, H Baumann and M J Dewey
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 918-922;
  7. Dildy-Mayfield, J E

    1. You have access
      Anesthetics produce subunit-selective actions on glutamate receptors.
      J E Dildy-Mayfield, E I Eger and R A Harris
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1058-1065;
  8. Dol, F

    1. You have access
      DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
      J M Herbert, A Bernat, F Dol, J P Hérault, B Crépon and J C Lormeau
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1030-1038;
  9. Douglas, J S

    1. You have access
      H+-K+ ATPase inhibitors cause relaxation of guinea pig and human airway smooth muscle in vitro.
      K J Rhoden, G Tallini and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 897-903;
  10. Dumont, F J

    1. You have access
      Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.
      F J Dumont, H Ok, S Lin, C A Kastner, J Cryan, M M Martin, G Wiederrecht and M J Staruch
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1078-1088;

E

  1. Eger, E I

    1. You have access
      Anesthetics produce subunit-selective actions on glutamate receptors.
      J E Dildy-Mayfield, E I Eger and R A Harris
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1058-1065;
  2. Erdmann, E

    1. You have access
      Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
      R H Schwinger, J Müller-Ehmsen, M Böhm and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1180-1188;

F

  1. Fan, N Y

    1. You have access
      Lack of antidiuretic activity of lanreotide in the diabetes insipidus rat.
      N Y Fan, C A Powers and C T Stier
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 875-881;
  2. Feigin, E

    1. You have access
      Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium.
      O Porat, D Neumann, O Zamir, S Nachshon, E Feigin, J Cohen and N Zamir
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1162-1168;
  3. Fincher, T K

    1. You have access
      Altered disposition and antidepressant activity of imipramine in transgenic mice with elevated alpha-1-acid glycoprotein.
      S D Yoo, J W Holladay, T K Fincher, H Baumann and M J Dewey
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 918-922;
  4. Fleming, W E

    1. You have access
      The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion.
      B M Taylor, W E Fleming, C W Benjamin, Y Wu, W R Mathews and F F Sun
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1224-1231;
  5. Freeman, L C

    1. You have access
      Dual actions of the novel class III antiarrhythmic drug NE-10064 on delayed potassium channel currents in guinea pig ventricular and sinoatrial node cells.
      M P Davies, L C Freeman and R S Kass
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1149-1154;
  6. Fuseau, C

    1. You have access
      Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.
      L Schmid, M Bottlaender, E Brouillet, C Fuseau and M Mazière
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 977-983;

G

  1. Gallager, D W

    1. You have access
      Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity.
      R J Primus, J Yu, J Xu, C Hartnett, M Meyyappan, C Kostas, T V Ramabhadran and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 882-890;
  2. Gallagher, J P

    1. You have access
      Modification of serotonin responses in rat dorsolateral septal nucleus neurons by acute and chronic cocaine.
      D Simms and J P Gallagher
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1292-1303;
  3. Gawin, A Z

    1. You have access
      Effects of bombesin family peptides and antagonists on guinea pig nasal mucosal secretion.
      M Ali, A Z Gawin and J N Baraniuk
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1266-1271;
  4. Gerber, J G

    1. You have access
      The effect of beta andrenoceptor stimulation of canine stomach on pentagastrin-stimulated histamine release.
      N A Payne and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 984-988;
  5. Gibb, J W

    1. You have access
      Methcathinone: an initial study of its effects on monoaminergic systems.
      M P Gygi, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1066-1072;
  6. Glavin, G B

    1. You have access
      Isolated rat gastric mucosal cells: optimal conditions for cell harvesting, measures of viability and direct cytoprotection.
      G B Glavin, S Szabo, B R Johnson, P L Xing, R E Morales, M Plebani and L Nagy
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1174-1179;
  7. Grinnell, B W

    1. You have access
      Evaluation of activated protein C on canine infarct size in a nonthrombotic model of myocardial reperfusion injury.
      R A Hahn, B R MacDonald, M Chastain, B W Grinnell and P J Simpson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1104-1110;
  8. Gygi, M P

    1. You have access
      Methcathinone: an initial study of its effects on monoaminergic systems.
      M P Gygi, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1066-1072;

H

  1. Hagenbuch, B

    1. You have access
      Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
      X Bossuyt, M Müller, B Hagenbuch and P J Meier
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 891-896;
  2. Hahn, R A

    1. You have access
      Evaluation of activated protein C on canine infarct size in a nonthrombotic model of myocardial reperfusion injury.
      R A Hahn, B R MacDonald, M Chastain, B W Grinnell and P J Simpson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1104-1110;
  3. Hameedi, F A

    1. You have access
      Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
      M I Rosen, T J McMahon, F A Hameedi, H R Pearsall, S W Woods, M J Kreek and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1128-1135;
  4. Hanson, G R

    1. You have access
      Methcathinone: an initial study of its effects on monoaminergic systems.
      M P Gygi, J W Gibb and G R Hanson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1066-1072;
  5. Harris, R A

    1. You have access
      Anesthetics produce subunit-selective actions on glutamate receptors.
      J E Dildy-Mayfield, E I Eger and R A Harris
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1058-1065;
  6. Hartnett, C

    1. You have access
      Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity.
      R J Primus, J Yu, J Xu, C Hartnett, M Meyyappan, C Kostas, T V Ramabhadran and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 882-890;
  7. Hérault, J P

    1. You have access
      DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
      J M Herbert, A Bernat, F Dol, J P Hérault, B Crépon and J C Lormeau
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1030-1038;
  8. Herbert, J M

    1. You have access
      DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
      J M Herbert, A Bernat, F Dol, J P Hérault, B Crépon and J C Lormeau
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1030-1038;
  9. Hill, M A

    1. You have access
      Calcium dependence of indolactam-mediated contractions in resistance vessels.
      M A Hill, M J Davis, J Song and H Zou
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 867-874;
  10. Hoeger, C

    1. You have access
      Development of a selective agonist at the somatostatin receptor subtype sstr1.
      G Liapakis, C Hoeger, J Rivier and T Reisine
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1089-1094;
  11. Holladay, J W

    1. You have access
      Altered disposition and antidepressant activity of imipramine in transgenic mice with elevated alpha-1-acid glycoprotein.
      S D Yoo, J W Holladay, T K Fincher, H Baumann and M J Dewey
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 918-922;
  12. Holsapple, M P

    1. You have access
      Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, S S Park and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1257-1265;
  13. Hruby, V J

    1. You have access
      Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
      T J Abbruscato, S A Williams, A Misicka, A W Lipkowski, V J Hruby and T P Davis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1049-1057;
  14. Hsu, K

    1. You have access
      Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization.
      M S Reid, K Hsu, B K Tolliver, C A Crawford and S P Berger
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1244-1256;

I

  1. Inotsume, N

    1. You have access
      Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: interaction with organic cation transporters in apical and basolateral membranes.
      T Ohtomo, H Saito, N Inotsume, M Yasuhara and K I Inui
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1143-1148;
  2. Inui, K I

    1. You have access
      Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: interaction with organic cation transporters in apical and basolateral membranes.
      T Ohtomo, H Saito, N Inotsume, M Yasuhara and K I Inui
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1143-1148;

J

  1. Jeong, T C

    1. You have access
      Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, S S Park and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1257-1265;
  2. Johnson, B R

    1. You have access
      Isolated rat gastric mucosal cells: optimal conditions for cell harvesting, measures of viability and direct cytoprotection.
      G B Glavin, S Szabo, B R Johnson, P L Xing, R E Morales, M Plebani and L Nagy
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1174-1179;
  3. Jordan, S D

    1. You have access
      Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, S S Park and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1257-1265;

K

  1. Kalant, H

    1. You have access
      Development of alcohol tolerance in the rat after a single exposure to combined treatment with arginine8-vasopressin and ethanol.
      P H Wu, J F Liu, W L Wu, A J Lança and H Kalant
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1283-1291;
  2. Kamenka, J M

    1. You have access
      Effects of repeated administration of N-[1-(2-benzo(b)-thiophenyl)cyclohexy]piperidine and cocaine on locomotor activity in C57BL/6 mice.
      E P Prinssen, M S Kleven, J Vignon, J M Kamenka and W Koek
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 904-911;
  3. Kan, H

    1. You have access
      Localization and characterization of the subtypes(s) of muscarinic receptor involved in prostacyclin synthesis in rabbit heart.
      H Kan, Y Ruan and U Malik K
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 934-941;
  4. Kass, R S

    1. You have access
      Dual actions of the novel class III antiarrhythmic drug NE-10064 on delayed potassium channel currents in guinea pig ventricular and sinoatrial node cells.
      M P Davies, L C Freeman and R S Kass
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1149-1154;
  5. Kastner, C A

    1. You have access
      Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.
      F J Dumont, H Ok, S Lin, C A Kastner, J Cryan, M M Martin, G Wiederrecht and M J Staruch
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1078-1088;
  6. Kathmann, M

    1. You have access
      Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?.
      R Leurs, M Kathmann, R C Vollinga, W M Menge, E Schlicker and H Timmerman
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1009-1015;
  7. Klaassen, C D

    1. You have access
      Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
      J Liu, Y Liu, A E Michalska, K H Choo and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1216-1223;
  8. Kleven, M S

    1. You have access
      Effects of repeated administration of N-[1-(2-benzo(b)-thiophenyl)cyclohexy]piperidine and cocaine on locomotor activity in C57BL/6 mice.
      E P Prinssen, M S Kleven, J Vignon, J M Kamenka and W Koek
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 904-911;
  9. Koek, W

    1. You have access
      Effects of repeated administration of N-[1-(2-benzo(b)-thiophenyl)cyclohexy]piperidine and cocaine on locomotor activity in C57BL/6 mice.
      E P Prinssen, M S Kleven, J Vignon, J M Kamenka and W Koek
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 904-911;
  10. Kostas, C

    1. You have access
      Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity.
      R J Primus, J Yu, J Xu, C Hartnett, M Meyyappan, C Kostas, T V Ramabhadran and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 882-890;
  11. Kosten, T R

    1. You have access
      Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
      M I Rosen, T J McMahon, F A Hameedi, H R Pearsall, S W Woods, M J Kreek and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1128-1135;
  12. Kreek, M J

    1. You have access
      Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
      M I Rosen, T J McMahon, F A Hameedi, H R Pearsall, S W Woods, M J Kreek and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1128-1135;

L

  1. Lança, A J

    1. You have access
      Development of alcohol tolerance in the rat after a single exposure to combined treatment with arginine8-vasopressin and ethanol.
      P H Wu, J F Liu, W L Wu, A J Lança and H Kalant
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1283-1291;
  2. Lavielle, S

    1. You have access
      Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
      S Sagan, G Chassaing, L Pradier and S Lavielle
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1039-1048;
  3. Le Bars, D

    1. You have access
      Effects of intravenous nonsteroidal antiinflammatory drugs on a C-fiber reflex elicited by a wide range of stimulus intensities in the rat.
      D Bustamante, C Paeile, J C Willer and D Le Bars
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1232-1243;
  4. Leist, M

    1. You have access
      Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines.
      M Leist, S Auer-Barth and A Wendel
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 968-976;
  5. Leurs, R

    1. You have access
      Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?.
      R Leurs, M Kathmann, R C Vollinga, W M Menge, E Schlicker and H Timmerman
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1009-1015;
  6. Levine, M

    1. You have access
      Inhibitory action of palytoxin on ascorbic acid transport into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Oka and M Levine
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 996-1001;
  7. Lewis, J M

    1. You have access
      Induction of apoptosis by organotin compounds in vitro: neuronal protection with antisense oligonucleotides directed against stannin.
      T A Thompson, J M Lewis, N S Dejneka, W B Severs, R Polavarapu and M L Billingsley
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1201-1216;
  8. Liapakis, G

    1. You have access
      Development of a selective agonist at the somatostatin receptor subtype sstr1.
      G Liapakis, C Hoeger, J Rivier and T Reisine
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1089-1094;
  9. Lin, C W

    1. You have access
      Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
      C W Lin, B R Bianchi, T R Miller, M A Stashko, S S Wang, P Curzon, L Bednarz, K E Asin and D R Britton
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1022-1029;
  10. Lin, Q

    1. You have access
      Antinociception and inhibition from the periaqueductal gray are mediated in part by spinal 5-hydroxytryptamine(1A) receptors.
      Q Lin, Y B Peng and W D Willis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 958-967;
  11. Lin, S

    1. You have access
      Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.
      F J Dumont, H Ok, S Lin, C A Kastner, J Cryan, M M Martin, G Wiederrecht and M J Staruch
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1078-1088;
  12. Lipkowski, A W

    1. You have access
      Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
      T J Abbruscato, S A Williams, A Misicka, A W Lipkowski, V J Hruby and T P Davis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1049-1057;
  13. Liu, J

    1. You have access
      Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
      J Liu, Y Liu, A E Michalska, K H Choo and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1216-1223;
  14. Liu, J F

    1. You have access
      Development of alcohol tolerance in the rat after a single exposure to combined treatment with arginine8-vasopressin and ethanol.
      P H Wu, J F Liu, W L Wu, A J Lança and H Kalant
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1283-1291;
  15. Liu, Y

    1. You have access
      Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
      J Liu, Y Liu, A E Michalska, K H Choo and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1216-1223;
  16. Lormeau, J C

    1. You have access
      DX 9065A a novel, synthetic, selective and orally active inhibitor of factor Xa: in vitro and in vivo studies.
      J M Herbert, A Bernat, F Dol, J P Hérault, B Crépon and J C Lormeau
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1030-1038;

M

  1. MacDonald, B R

    1. You have access
      Evaluation of activated protein C on canine infarct size in a nonthrombotic model of myocardial reperfusion injury.
      R A Hahn, B R MacDonald, M Chastain, B W Grinnell and P J Simpson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1104-1110;
  2. Madras, B K

    1. You have access
      Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
      J Bergman, R D Spealman, B K Madras and S Rosenzweig-Lipson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 942-950;
  3. Malik K, U

    1. You have access
      Localization and characterization of the subtypes(s) of muscarinic receptor involved in prostacyclin synthesis in rabbit heart.
      H Kan, Y Ruan and U Malik K
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 934-941;
  4. Martin, M M

    1. You have access
      Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.
      F J Dumont, H Ok, S Lin, C A Kastner, J Cryan, M M Martin, G Wiederrecht and M J Staruch
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1078-1088;
  5. Mathews, W R

    1. You have access
      The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion.
      B M Taylor, W E Fleming, C W Benjamin, Y Wu, W R Mathews and F F Sun
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1224-1231;
  6. Matsuyama, S

    1. You have access
      Identification of putative 5-hydroxytryptamine(4) (5-HT4) receptors in guinea pig stomach: The effect of TKS159, a novel agonist, on gastric motility and acetylcholine release.
      S Matsuyama, H Sakiyama, K Nei and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 989-995;
  7. Matulka, R A

    1. You have access
      Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, S S Park and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1257-1265;
  8. Mazière, M

    1. You have access
      Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.
      L Schmid, M Bottlaender, E Brouillet, C Fuseau and M Mazière
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 977-983;
  9. McMahon, T J

    1. You have access
      Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
      M I Rosen, T J McMahon, F A Hameedi, H R Pearsall, S W Woods, M J Kreek and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1128-1135;
  10. Meier, P J

    1. You have access
      Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
      X Bossuyt, M Müller, B Hagenbuch and P J Meier
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 891-896;
  11. Mele, P C

    1. You have access
      Comparison of the effects of typical and atypical anxiolytics on learning in monkeys and rats.
      P J Winsauer, M A Bixler and P C Mele
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1111-1127;
  12. Melnychuk, D

    1. You have access
      Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response.
      T Wang, X Chen, R L Schecter, S Baruchel, M Alaoui-Jamali, D Melnychuk and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1169-1173;
  13. Menge, W M

    1. You have access
      Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?.
      R Leurs, M Kathmann, R C Vollinga, W M Menge, E Schlicker and H Timmerman
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1009-1015;
  14. Meyyappan, M

    1. You have access
      Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity.
      R J Primus, J Yu, J Xu, C Hartnett, M Meyyappan, C Kostas, T V Ramabhadran and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 882-890;
  15. Michalska, A E

    1. You have access
      Metallothionein plays less of a protective role in cadmium-metallothionein-induced nephrotoxicity than in cadmium chloride-induced hepatotoxicity.
      J Liu, Y Liu, A E Michalska, K H Choo and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1216-1223;
  16. Miller, T R

    1. You have access
      Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
      C W Lin, B R Bianchi, T R Miller, M A Stashko, S S Wang, P Curzon, L Bednarz, K E Asin and D R Britton
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1022-1029;
  17. Misicka, A

    1. You have access
      Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
      T J Abbruscato, S A Williams, A Misicka, A W Lipkowski, V J Hruby and T P Davis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1049-1057;
  18. Morales, R E

    1. You have access
      Isolated rat gastric mucosal cells: optimal conditions for cell harvesting, measures of viability and direct cytoprotection.
      G B Glavin, S Szabo, B R Johnson, P L Xing, R E Morales, M Plebani and L Nagy
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1174-1179;
  19. Morita, K

    1. You have access
      Inhibitory action of palytoxin on ascorbic acid transport into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Oka and M Levine
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 996-1001;
  20. Mulder, G J

    1. You have access
      Isoenzyme-selective inhibition of glutathione conjugation in vivo: selective inhibition of the conjugation of S-2-Bromoisovalerylurea in the rat.
      S Ouwerkerk-Mahadevan, J H van Boom and G J Mulder
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 923-928;
  21. Müller, M

    1. You have access
      Polyspecific drug and steroid clearance by an organic anion transporter of mammalian liver.
      X Bossuyt, M Müller, B Hagenbuch and P J Meier
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 891-896;
  22. Müller-Ehmsen, J

    1. You have access
      Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
      R H Schwinger, J Müller-Ehmsen, M Böhm and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1180-1188;

N

  1. Nachshon, S

    1. You have access
      Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium.
      O Porat, D Neumann, O Zamir, S Nachshon, E Feigin, J Cohen and N Zamir
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1162-1168;
  2. Nagy, L

    1. You have access
      Isolated rat gastric mucosal cells: optimal conditions for cell harvesting, measures of viability and direct cytoprotection.
      G B Glavin, S Szabo, B R Johnson, P L Xing, R E Morales, M Plebani and L Nagy
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1174-1179;
  3. Nei, K

    1. You have access
      Identification of putative 5-hydroxytryptamine(4) (5-HT4) receptors in guinea pig stomach: The effect of TKS159, a novel agonist, on gastric motility and acetylcholine release.
      S Matsuyama, H Sakiyama, K Nei and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 989-995;
  4. Neumann, D

    1. You have access
      Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium.
      O Porat, D Neumann, O Zamir, S Nachshon, E Feigin, J Cohen and N Zamir
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1162-1168;

O

  1. Ocaña, M

    1. You have access
      Cromakalim differentially enhances antinociception induced by agonists of alpha(2)adrenoceptors, gamma-aminobutyric acid(B), mu and kappa opioid receptors.
      M Ocaña, M Barrios and J M Baeyens
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1136-1142;
  2. Ohtomo, T

    1. You have access
      Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: interaction with organic cation transporters in apical and basolateral membranes.
      T Ohtomo, H Saito, N Inotsume, M Yasuhara and K I Inui
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1143-1148;
  3. Ok, H

    1. You have access
      Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.
      F J Dumont, H Ok, S Lin, C A Kastner, J Cryan, M M Martin, G Wiederrecht and M J Staruch
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1078-1088;
  4. Oka, M

    1. You have access
      Inhibitory action of palytoxin on ascorbic acid transport into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Oka and M Levine
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 996-1001;
  5. Ouwerkerk-Mahadevan, S

    1. You have access
      Isoenzyme-selective inhibition of glutathione conjugation in vivo: selective inhibition of the conjugation of S-2-Bromoisovalerylurea in the rat.
      S Ouwerkerk-Mahadevan, J H van Boom and G J Mulder
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 923-928;

P

  1. Paeile, C

    1. You have access
      Effects of intravenous nonsteroidal antiinflammatory drugs on a C-fiber reflex elicited by a wide range of stimulus intensities in the rat.
      D Bustamante, C Paeile, J C Willer and D Le Bars
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1232-1243;
  2. Pang, P K

    1. You have access
      The vasorelaxing action of rutaecarpine: direct paradoxical effects on intracellular calcium concentration of vascular smooth muscle and endothelial cells.
      G J Wang, J Shan, P K Pang, M C Yang, C J Chou and C F Chen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1016-1021;
  3. Park, I

    1. You have access
      Stimulation of renin secretion by the phosphodiesterase IV inhibitor rolipram.
      N Chiu, I Park and I A Reid
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1073-1077;
  4. Park, S S

    1. You have access
      Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, S S Park and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1257-1265;
  5. Payne, N A

    1. You have access
      The effect of beta andrenoceptor stimulation of canine stomach on pentagastrin-stimulated histamine release.
      N A Payne and J G Gerber
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 984-988;
  6. Pearsall, H R

    1. You have access
      Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
      M I Rosen, T J McMahon, F A Hameedi, H R Pearsall, S W Woods, M J Kreek and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1128-1135;
  7. Peng, Y B

    1. You have access
      Antinociception and inhibition from the periaqueductal gray are mediated in part by spinal 5-hydroxytryptamine(1A) receptors.
      Q Lin, Y B Peng and W D Willis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 958-967;
  8. Peris, J

    1. You have access
      Repeated cocaine injections decrease the function of striatal gamma-aminobutyric acid(A) receptors.
      J Peris
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1002-1008;
  9. Plebani, M

    1. You have access
      Isolated rat gastric mucosal cells: optimal conditions for cell harvesting, measures of viability and direct cytoprotection.
      G B Glavin, S Szabo, B R Johnson, P L Xing, R E Morales, M Plebani and L Nagy
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1174-1179;
  10. Polavarapu, R

    1. You have access
      Induction of apoptosis by organotin compounds in vitro: neuronal protection with antisense oligonucleotides directed against stannin.
      T A Thompson, J M Lewis, N S Dejneka, W B Severs, R Polavarapu and M L Billingsley
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1201-1216;
  11. Porat, O

    1. You have access
      Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium.
      O Porat, D Neumann, O Zamir, S Nachshon, E Feigin, J Cohen and N Zamir
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1162-1168;
  12. Powers, C A

    1. You have access
      Lack of antidiuretic activity of lanreotide in the diabetes insipidus rat.
      N Y Fan, C A Powers and C T Stier
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 875-881;
  13. Pradier, L

    1. You have access
      Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
      S Sagan, G Chassaing, L Pradier and S Lavielle
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1039-1048;
  14. Primus, R J

    1. You have access
      Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity.
      R J Primus, J Yu, J Xu, C Hartnett, M Meyyappan, C Kostas, T V Ramabhadran and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 882-890;
  15. Prinssen, E P

    1. You have access
      Effects of repeated administration of N-[1-(2-benzo(b)-thiophenyl)cyclohexy]piperidine and cocaine on locomotor activity in C57BL/6 mice.
      E P Prinssen, M S Kleven, J Vignon, J M Kamenka and W Koek
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 904-911;

R

  1. Raasch, W

    1. You have access
      Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
      S Regunathan, C Youngson, W Raasch, H Wang and D J Reis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1272-1282;
  2. Ramabhadran, T V

    1. You have access
      Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity.
      R J Primus, J Yu, J Xu, C Hartnett, M Meyyappan, C Kostas, T V Ramabhadran and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 882-890;
  3. Regunathan, S

    1. You have access
      Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
      S Regunathan, C Youngson, W Raasch, H Wang and D J Reis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1272-1282;
  4. Reid, I A

    1. You have access
      Stimulation of renin secretion by the phosphodiesterase IV inhibitor rolipram.
      N Chiu, I Park and I A Reid
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1073-1077;
  5. Reid, M S

    1. You have access
      Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization.
      M S Reid, K Hsu, B K Tolliver, C A Crawford and S P Berger
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1244-1256;
  6. Reis, D J

    1. You have access
      Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
      S Regunathan, C Youngson, W Raasch, H Wang and D J Reis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1272-1282;
  7. Reisine, T

    1. You have access
      Development of a selective agonist at the somatostatin receptor subtype sstr1.
      G Liapakis, C Hoeger, J Rivier and T Reisine
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1089-1094;
  8. Rhoden, K J

    1. You have access
      H+-K+ ATPase inhibitors cause relaxation of guinea pig and human airway smooth muscle in vitro.
      K J Rhoden, G Tallini and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 897-903;
  9. Rivier, J

    1. You have access
      Development of a selective agonist at the somatostatin receptor subtype sstr1.
      G Liapakis, C Hoeger, J Rivier and T Reisine
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1089-1094;
  10. Rosen, M I

    1. You have access
      Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
      M I Rosen, T J McMahon, F A Hameedi, H R Pearsall, S W Woods, M J Kreek and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1128-1135;
  11. Rosenzweig-Lipson, S

    1. You have access
      Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
      J Bergman, R D Spealman, B K Madras and S Rosenzweig-Lipson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 942-950;
  12. Ruan, Y

    1. You have access
      Localization and characterization of the subtypes(s) of muscarinic receptor involved in prostacyclin synthesis in rabbit heart.
      H Kan, Y Ruan and U Malik K
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 934-941;

S

  1. Sagan, S

    1. You have access
      Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors.
      S Sagan, G Chassaing, L Pradier and S Lavielle
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1039-1048;
  2. Saito, H

    1. You have access
      Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: interaction with organic cation transporters in apical and basolateral membranes.
      T Ohtomo, H Saito, N Inotsume, M Yasuhara and K I Inui
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1143-1148;
  3. Sakiyama, H

    1. You have access
      Identification of putative 5-hydroxytryptamine(4) (5-HT4) receptors in guinea pig stomach: The effect of TKS159, a novel agonist, on gastric motility and acetylcholine release.
      S Matsuyama, H Sakiyama, K Nei and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 989-995;
  4. Sanguinetti, M C

    1. You have access
      Intracellular [Mg++] determines specificity of K+ channel block by a class III antiarrhythmic drug.
      G Z Sudo and M C Sanguinetti
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 951-957;
  5. Schecter, R L

    1. You have access
      Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response.
      T Wang, X Chen, R L Schecter, S Baruchel, M Alaoui-Jamali, D Melnychuk and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1169-1173;
  6. Schlicker, E

    1. You have access
      Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?.
      R Leurs, M Kathmann, R C Vollinga, W M Menge, E Schlicker and H Timmerman
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1009-1015;
  7. Schmid, L

    1. You have access
      Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.
      L Schmid, M Bottlaender, E Brouillet, C Fuseau and M Mazière
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 977-983;
  8. Schwinger, R H

    1. You have access
      Enantioselective inotropic actions of the Na+-channel activators BDF 9148, BDF 9196 and BDF 9167 in human failing and nonfailing myocardium.
      R H Schwinger, J Müller-Ehmsen, M Böhm and E Erdmann
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1180-1188;
  9. Severs, W B

    1. You have access
      Induction of apoptosis by organotin compounds in vitro: neuronal protection with antisense oligonucleotides directed against stannin.
      T A Thompson, J M Lewis, N S Dejneka, W B Severs, R Polavarapu and M L Billingsley
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1201-1216;
  10. Shan, J

    1. You have access
      The vasorelaxing action of rutaecarpine: direct paradoxical effects on intracellular calcium concentration of vascular smooth muscle and endothelial cells.
      G J Wang, J Shan, P K Pang, M C Yang, C J Chou and C F Chen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1016-1021;
  11. Shen, D D

    1. You have access
      Uptake of valproic acid into rat brain is mediated by a medium-chain fatty acid transporter.
      K D Adkison and D D Shen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1189-1200;
  12. Simms, D

    1. You have access
      Modification of serotonin responses in rat dorsolateral septal nucleus neurons by acute and chronic cocaine.
      D Simms and J P Gallagher
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1292-1303;
  13. Simpson, P J

    1. You have access
      Evaluation of activated protein C on canine infarct size in a nonthrombotic model of myocardial reperfusion injury.
      R A Hahn, B R MacDonald, M Chastain, B W Grinnell and P J Simpson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1104-1110;
  14. Song, J

    1. You have access
      Calcium dependence of indolactam-mediated contractions in resistance vessels.
      M A Hill, M J Davis, J Song and H Zou
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 867-874;
  15. Spealman, R D

    1. You have access
      Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
      J Bergman, R D Spealman, B K Madras and S Rosenzweig-Lipson
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 942-950;
  16. Stanulis, E D

    1. You have access
      Immunosuppression induced by acute exposure to cocaine is dependent on metabolism by cytochrome P-450.
      T C Jeong, S D Jordan, R A Matulka, E D Stanulis, S S Park and M P Holsapple
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1257-1265;
  17. Staruch, M J

    1. You have access
      Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.
      F J Dumont, H Ok, S Lin, C A Kastner, J Cryan, M M Martin, G Wiederrecht and M J Staruch
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1078-1088;
  18. Stashko, M A

    1. You have access
      Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
      C W Lin, B R Bianchi, T R Miller, M A Stashko, S S Wang, P Curzon, L Bednarz, K E Asin and D R Britton
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1022-1029;
  19. Stier, C T

    1. You have access
      Lack of antidiuretic activity of lanreotide in the diabetes insipidus rat.
      N Y Fan, C A Powers and C T Stier
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 875-881;
  20. Sudo, G Z

    1. You have access
      Intracellular [Mg++] determines specificity of K+ channel block by a class III antiarrhythmic drug.
      G Z Sudo and M C Sanguinetti
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 951-957;
  21. Sun, F F

    1. You have access
      The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion.
      B M Taylor, W E Fleming, C W Benjamin, Y Wu, W R Mathews and F F Sun
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1224-1231;
  22. Szabo, S

    1. You have access
      Isolated rat gastric mucosal cells: optimal conditions for cell harvesting, measures of viability and direct cytoprotection.
      G B Glavin, S Szabo, B R Johnson, P L Xing, R E Morales, M Plebani and L Nagy
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1174-1179;

T

  1. Tallini, G

    1. You have access
      H+-K+ ATPase inhibitors cause relaxation of guinea pig and human airway smooth muscle in vitro.
      K J Rhoden, G Tallini and J S Douglas
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 897-903;
  2. Tanaka, C

    1. You have access
      Identification of putative 5-hydroxytryptamine(4) (5-HT4) receptors in guinea pig stomach: The effect of TKS159, a novel agonist, on gastric motility and acetylcholine release.
      S Matsuyama, H Sakiyama, K Nei and C Tanaka
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 989-995;
  3. Taylor, B M

    1. You have access
      The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion.
      B M Taylor, W E Fleming, C W Benjamin, Y Wu, W R Mathews and F F Sun
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1224-1231;
  4. Teraoka, K

    1. You have access
      Inhibitory action of palytoxin on ascorbic acid transport into cultured bovine adrenal chromaffin cells.
      K Morita, K Teraoka, M Oka and M Levine
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 996-1001;
  5. Thom, S R

    1. You have access
      Functional inhibition of rat polymorphonuclear leukocyte B2 integrins by hyperbaric oxygen is associated with impaired cGMP synthesis.
      Q Chen, P D Banick and S R Thom
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 929-933;
  6. Thompson, T A

    1. You have access
      Induction of apoptosis by organotin compounds in vitro: neuronal protection with antisense oligonucleotides directed against stannin.
      T A Thompson, J M Lewis, N S Dejneka, W B Severs, R Polavarapu and M L Billingsley
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1201-1216;
  7. Timmerman, H

    1. You have access
      Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?.
      R Leurs, M Kathmann, R C Vollinga, W M Menge, E Schlicker and H Timmerman
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1009-1015;
  8. Tjia, J F

    1. You have access
      Theophylline metabolism in human liver microsomes: inhibition studies.
      J F Tjia, J Colbert and D J Back
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 912-917;
  9. Tolliver, B K

    1. You have access
      Evidence for the involvement of phospholipase A2 mechanisms in the development of stimulant sensitization.
      M S Reid, K Hsu, B K Tolliver, C A Crawford and S P Berger
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1244-1256;

V

  1. van Boom, J H

    1. You have access
      Isoenzyme-selective inhibition of glutathione conjugation in vivo: selective inhibition of the conjugation of S-2-Bromoisovalerylurea in the rat.
      S Ouwerkerk-Mahadevan, J H van Boom and G J Mulder
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 923-928;
  2. Varma, D R

    1. You have access
      Ontogenic differences in the functions of myocardial alpha1 adrenoceptor subtypes in rats.
      X F Deng, S Chemtob, G Almazan and D R Varma
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1155-1161;
  3. Vignon, J

    1. You have access
      Effects of repeated administration of N-[1-(2-benzo(b)-thiophenyl)cyclohexy]piperidine and cocaine on locomotor activity in C57BL/6 mice.
      E P Prinssen, M S Kleven, J Vignon, J M Kamenka and W Koek
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 904-911;
  4. Vollinga, R C

    1. You have access
      Histamine homologues discriminating between two functional H3 receptor assays. Evidence for H3 receptor heterogeneity?.
      R Leurs, M Kathmann, R C Vollinga, W M Menge, E Schlicker and H Timmerman
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1009-1015;

W

  1. Wang, G J

    1. You have access
      The vasorelaxing action of rutaecarpine: direct paradoxical effects on intracellular calcium concentration of vascular smooth muscle and endothelial cells.
      G J Wang, J Shan, P K Pang, M C Yang, C J Chou and C F Chen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1016-1021;
  2. Wang, H

    1. You have access
      Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
      S Regunathan, C Youngson, W Raasch, H Wang and D J Reis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1272-1282;
  3. Wang, S S

    1. You have access
      Persistent activation of the dopamine D1 receptor contributes to prolonged receptor desensitization: studies with A-77636.
      C W Lin, B R Bianchi, T R Miller, M A Stashko, S S Wang, P Curzon, L Bednarz, K E Asin and D R Britton
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1022-1029;
  4. Wang, T

    1. You have access
      Modulation of glutathione by a cysteine pro-drug enhances in vivo tumor response.
      T Wang, X Chen, R L Schecter, S Baruchel, M Alaoui-Jamali, D Melnychuk and G Batist
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1169-1173;
  5. Wendel, A

    1. You have access
      Tumor necrosis factor production in the perfused mouse liver and its pharmacological modulation by methylxanthines.
      M Leist, S Auer-Barth and A Wendel
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 968-976;
  6. Wiederrecht, G

    1. You have access
      Mixed agonist/antagonist activity of an FK-506-related immunosuppressant: biological and biochemical characterization.
      F J Dumont, H Ok, S Lin, C A Kastner, J Cryan, M M Martin, G Wiederrecht and M J Staruch
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1078-1088;
  7. Willer, J C

    1. You have access
      Effects of intravenous nonsteroidal antiinflammatory drugs on a C-fiber reflex elicited by a wide range of stimulus intensities in the rat.
      D Bustamante, C Paeile, J C Willer and D Le Bars
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1232-1243;
  8. Williams, S A

    1. You have access
      Blood-to-central nervous system entry and stability of biphalin, a unique double-enkephalin analog, and its halogenated derivatives.
      T J Abbruscato, S A Williams, A Misicka, A W Lipkowski, V J Hruby and T P Davis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1049-1057;
  9. Willis, W D

    1. You have access
      Antinociception and inhibition from the periaqueductal gray are mediated in part by spinal 5-hydroxytryptamine(1A) receptors.
      Q Lin, Y B Peng and W D Willis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 958-967;
  10. Winsauer, P J

    1. You have access
      Comparison of the effects of typical and atypical anxiolytics on learning in monkeys and rats.
      P J Winsauer, M A Bixler and P C Mele
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1111-1127;
  11. Woods, S W

    1. You have access
      Effect of clonidine pretreatment on naloxone-precipitated opiate withdrawal.
      M I Rosen, T J McMahon, F A Hameedi, H R Pearsall, S W Woods, M J Kreek and T R Kosten
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1128-1135;
  12. Wu, P H

    1. You have access
      Development of alcohol tolerance in the rat after a single exposure to combined treatment with arginine8-vasopressin and ethanol.
      P H Wu, J F Liu, W L Wu, A J Lança and H Kalant
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1283-1291;
  13. Wu, W L

    1. You have access
      Development of alcohol tolerance in the rat after a single exposure to combined treatment with arginine8-vasopressin and ethanol.
      P H Wu, J F Liu, W L Wu, A J Lança and H Kalant
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1283-1291;
  14. Wu, Y

    1. You have access
      The mechanism of cytoprotective action of lazaroids I: Inhibition of reactive oxygen species formation and lethal cell injury during periods of energy depletion.
      B M Taylor, W E Fleming, C W Benjamin, Y Wu, W R Mathews and F F Sun
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1224-1231;

X

  1. Xing, P L

    1. You have access
      Isolated rat gastric mucosal cells: optimal conditions for cell harvesting, measures of viability and direct cytoprotection.
      G B Glavin, S Szabo, B R Johnson, P L Xing, R E Morales, M Plebani and L Nagy
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1174-1179;
  2. Xu, J

    1. You have access
      Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity.
      R J Primus, J Yu, J Xu, C Hartnett, M Meyyappan, C Kostas, T V Ramabhadran and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 882-890;

Y

  1. Yang, M C

    1. You have access
      The vasorelaxing action of rutaecarpine: direct paradoxical effects on intracellular calcium concentration of vascular smooth muscle and endothelial cells.
      G J Wang, J Shan, P K Pang, M C Yang, C J Chou and C F Chen
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1016-1021;
  2. Yasuhara, M

    1. You have access
      Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: interaction with organic cation transporters in apical and basolateral membranes.
      T Ohtomo, H Saito, N Inotsume, M Yasuhara and K I Inui
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1143-1148;
  3. Yoo, S D

    1. You have access
      Altered disposition and antidepressant activity of imipramine in transgenic mice with elevated alpha-1-acid glycoprotein.
      S D Yoo, J W Holladay, T K Fincher, H Baumann and M J Dewey
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 918-922;
  4. Youngson, C

    1. You have access
      Imidazoline receptors and agmatine in blood vessels: a novel system inhibiting vascular smooth muscle proliferation.
      S Regunathan, C Youngson, W Raasch, H Wang and D J Reis
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1272-1282;
  5. Yu, J

    1. You have access
      Allosteric uncoupling after chronic benzodiazepine exposure of recombinant gamma-aminobutyric acid(A) receptors expressed in Sf9 cells: ligand efficacy and subtype selectivity.
      R J Primus, J Yu, J Xu, C Hartnett, M Meyyappan, C Kostas, T V Ramabhadran and D W Gallager
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 882-890;

Z

  1. Zamir, N

    1. You have access
      Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium.
      O Porat, D Neumann, O Zamir, S Nachshon, E Feigin, J Cohen and N Zamir
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1162-1168;
  2. Zamir, O

    1. You have access
      Erythropoietin stimulates atrial natriuretic peptide secretion from adult rat cardiac atrium.
      O Porat, D Neumann, O Zamir, S Nachshon, E Feigin, J Cohen and N Zamir
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 1162-1168;
  3. Zou, H

    1. You have access
      Calcium dependence of indolactam-mediated contractions in resistance vessels.
      M A Hill, M J Davis, J Song and H Zou
      Journal of Pharmacology and Experimental Therapeutics March 1996, 276 (3) 867-874;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 276, Issue 3
1 Mar 1996
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates.
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics